James O'Connell, III, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Public Housing | 3 | 2021 | 140 | 0.850 |
Why?
|
| Death | 3 | 2021 | 677 | 0.780 |
Why?
|
| Urban Health Services | 3 | 2010 | 176 | 0.600 |
Why?
|
| Safety | 1 | 2021 | 1151 | 0.540 |
Why?
|
| Medicare Part C | 1 | 2020 | 330 | 0.470 |
Why?
|
| Vulnerable Populations | 2 | 2016 | 706 | 0.430 |
Why?
|
| Cause of Death | 8 | 2022 | 3688 | 0.410 |
Why?
|
| Mortality | 7 | 2022 | 2896 | 0.360 |
Why?
|
| Philosophy, Medical | 1 | 2010 | 79 | 0.350 |
Why?
|
| Boston | 19 | 2021 | 9327 | 0.300 |
Why?
|
| Patient-Centered Care | 2 | 2016 | 1427 | 0.300 |
Why?
|
| Community Health Centers | 1 | 2010 | 461 | 0.270 |
Why?
|
| Community Health Planning | 1 | 2005 | 164 | 0.230 |
Why?
|
| Quality of Health Care | 2 | 2016 | 4320 | 0.230 |
Why?
|
| Morbidity | 3 | 2005 | 1751 | 0.220 |
Why?
|
| Urban Population | 2 | 2018 | 2036 | 0.210 |
Why?
|
| Healthcare Disparities | 2 | 2016 | 3354 | 0.210 |
Why?
|
| Public Health Administration | 1 | 2005 | 242 | 0.210 |
Why?
|
| Attitude to Death | 1 | 2005 | 400 | 0.190 |
Why?
|
| Social Problems | 1 | 2021 | 109 | 0.190 |
Why?
|
| Housing | 3 | 2021 | 669 | 0.160 |
Why?
|
| Health Services | 2 | 2016 | 750 | 0.160 |
Why?
|
| Frail Elderly | 1 | 2004 | 766 | 0.150 |
Why?
|
| Public Health Practice | 1 | 2020 | 219 | 0.150 |
Why?
|
| Hospice Care | 1 | 2005 | 678 | 0.150 |
Why?
|
| Public Health | 1 | 2010 | 2672 | 0.140 |
Why?
|
| United States | 12 | 2021 | 72339 | 0.120 |
Why?
|
| Needs Assessment | 2 | 2010 | 1141 | 0.110 |
Why?
|
| Delivery of Health Care | 4 | 2021 | 5333 | 0.110 |
Why?
|
| Humans | 40 | 2022 | 761208 | 0.100 |
Why?
|
| Health Services Accessibility | 5 | 2020 | 5425 | 0.100 |
Why?
|
| Terminal Care | 1 | 2005 | 1760 | 0.100 |
Why?
|
| Health Expenditures | 2 | 2021 | 2362 | 0.100 |
Why?
|
| Cost Savings | 1 | 2016 | 911 | 0.090 |
Why?
|
| Hunger | 1 | 2012 | 205 | 0.090 |
Why?
|
| Pandemics | 2 | 2021 | 8663 | 0.090 |
Why?
|
| Opioid-Related Disorders | 2 | 2021 | 2164 | 0.090 |
Why?
|
| Chronic Disease | 3 | 2020 | 9319 | 0.080 |
Why?
|
| Health Planning Guidelines | 1 | 2010 | 151 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2020 | 2598 | 0.080 |
Why?
|
| Respite Care | 1 | 2009 | 2 | 0.080 |
Why?
|
| Comprehensive Health Care | 1 | 2010 | 123 | 0.080 |
Why?
|
| Physicians | 1 | 2007 | 4584 | 0.080 |
Why?
|
| Hepatitis C, Chronic | 1 | 2017 | 1027 | 0.080 |
Why?
|
| Community-Institutional Relations | 1 | 2010 | 206 | 0.080 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2013 | 928 | 0.080 |
Why?
|
| Adult | 20 | 2022 | 221119 | 0.070 |
Why?
|
| Health Services for the Aged | 1 | 1990 | 258 | 0.070 |
Why?
|
| Primary Health Care | 3 | 2013 | 4678 | 0.070 |
Why?
|
| Models, Organizational | 1 | 2010 | 544 | 0.070 |
Why?
|
| Medicaid | 1 | 2020 | 2813 | 0.070 |
Why?
|
| Health Care Coalitions | 1 | 2005 | 36 | 0.060 |
Why?
|
| Quality of Life | 1 | 2007 | 13367 | 0.060 |
Why?
|
| Food Supply | 1 | 2011 | 539 | 0.060 |
Why?
|
| Antiviral Agents | 1 | 2017 | 3048 | 0.060 |
Why?
|
| Medically Uninsured | 1 | 2010 | 834 | 0.060 |
Why?
|
| Cohort Studies | 6 | 2021 | 41496 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2016 | 2493 | 0.060 |
Why?
|
| Malnutrition | 1 | 2011 | 622 | 0.060 |
Why?
|
| Respiratory Tract Infections | 1 | 1991 | 1009 | 0.060 |
Why?
|
| Middle Aged | 18 | 2021 | 220853 | 0.060 |
Why?
|
| Data Collection | 2 | 2011 | 3320 | 0.050 |
Why?
|
| Ontario | 1 | 2004 | 398 | 0.050 |
Why?
|
| Continuity of Patient Care | 1 | 2010 | 1069 | 0.050 |
Why?
|
| Oncology Service, Hospital | 1 | 2003 | 57 | 0.050 |
Why?
|
| Office Visits | 1 | 2007 | 593 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3093 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3215 | 0.050 |
Why?
|
| Health Services Research | 1 | 1990 | 1807 | 0.050 |
Why?
|
| Health Services Needs and Demand | 1 | 1990 | 1401 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2016 | 3808 | 0.050 |
Why?
|
| Male | 20 | 2021 | 360693 | 0.050 |
Why?
|
| Prisoners | 1 | 2005 | 314 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 3453 | 0.050 |
Why?
|
| Massachusetts | 2 | 2020 | 8837 | 0.040 |
Why?
|
| Harm Reduction | 1 | 2021 | 144 | 0.040 |
Why?
|
| Substance-Related Disorders | 2 | 2014 | 4413 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 15520 | 0.040 |
Why?
|
| Mobile Health Units | 1 | 2020 | 92 | 0.040 |
Why?
|
| Buprenorphine | 1 | 2007 | 656 | 0.040 |
Why?
|
| Female | 18 | 2021 | 392544 | 0.040 |
Why?
|
| Hospitals, Urban | 1 | 2001 | 500 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2013 | 3976 | 0.040 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2020 | 148 | 0.040 |
Why?
|
| Age Factors | 3 | 2020 | 18384 | 0.040 |
Why?
|
| Naloxone | 1 | 2021 | 370 | 0.040 |
Why?
|
| Quarantine | 1 | 2020 | 182 | 0.040 |
Why?
|
| Contact Tracing | 1 | 2020 | 272 | 0.040 |
Why?
|
| Violence | 1 | 2004 | 935 | 0.040 |
Why?
|
| Risk | 2 | 2013 | 9616 | 0.040 |
Why?
|
| Uridine Monophosphate | 1 | 2017 | 66 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2011 | 3200 | 0.030 |
Why?
|
| Antibiotics, Antitubercular | 1 | 1996 | 99 | 0.030 |
Why?
|
| Fluorenes | 1 | 2017 | 157 | 0.030 |
Why?
|
| Aged | 12 | 2020 | 169288 | 0.030 |
Why?
|
| Ribavirin | 1 | 2017 | 394 | 0.030 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 746 | 0.030 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 561 | 0.030 |
Why?
|
| Rifampin | 1 | 1996 | 338 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2009 | 3265 | 0.030 |
Why?
|
| Aging | 1 | 2013 | 8702 | 0.030 |
Why?
|
| Human Rights | 1 | 2016 | 308 | 0.030 |
Why?
|
| Young Adult | 6 | 2020 | 59221 | 0.030 |
Why?
|
| Alcohol-Related Disorders | 1 | 2014 | 238 | 0.030 |
Why?
|
| Drug Resistance, Viral | 1 | 2017 | 862 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2017 | 858 | 0.020 |
Why?
|
| Haemophilus Infections | 1 | 1991 | 94 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2003 | 2515 | 0.020 |
Why?
|
| Haemophilus influenzae | 1 | 1991 | 178 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2020 | 6067 | 0.020 |
Why?
|
| Population Dynamics | 1 | 2013 | 308 | 0.020 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 58952 | 0.020 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 1991 | 130 | 0.020 |
Why?
|
| Obesity | 1 | 2012 | 12939 | 0.020 |
Why?
|
| Neoplasms | 2 | 2018 | 22140 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 2017 | 6304 | 0.020 |
Why?
|
| Hepacivirus | 1 | 2017 | 1330 | 0.020 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1996 | 830 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1997 | 2196 | 0.020 |
Why?
|
| Palliative Care | 1 | 2005 | 3599 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2014 | 1256 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 6486 | 0.020 |
Why?
|
| Tobacco Use Disorder | 1 | 2014 | 703 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2017 | 2839 | 0.020 |
Why?
|
| Adolescent | 5 | 2020 | 88298 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 2003 | 2894 | 0.020 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 1996 | 934 | 0.020 |
Why?
|
| Viral Load | 1 | 2017 | 3328 | 0.020 |
Why?
|
| Risk Factors | 4 | 2020 | 74239 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1990 | 1624 | 0.020 |
Why?
|
| Retrospective Studies | 6 | 2017 | 80674 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 1996 | 1747 | 0.020 |
Why?
|
| Medical Records | 1 | 2012 | 1409 | 0.020 |
Why?
|
| Community Networks | 1 | 2009 | 201 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2020 | 2493 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2013 | 7804 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2018 | 54435 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2012 | 1723 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 3805 | 0.010 |
Why?
|
| Survival Rate | 1 | 2018 | 12728 | 0.010 |
Why?
|
| Eating | 1 | 2011 | 1535 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2004 | 6823 | 0.010 |
Why?
|
| Social Class | 1 | 2012 | 1993 | 0.010 |
Why?
|
| Genotype | 1 | 2017 | 12985 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2011 | 1597 | 0.010 |
Why?
|
| Mental Health Services | 1 | 2013 | 1716 | 0.010 |
Why?
|
| Influenza, Human | 1 | 1991 | 1521 | 0.010 |
Why?
|
| Health Status | 1 | 2013 | 4077 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2009 | 2489 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10553 | 0.010 |
Why?
|
| Hospitals, General | 1 | 2003 | 799 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2020 | 24021 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39126 | 0.010 |
Why?
|
| Time Factors | 1 | 2018 | 39957 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2007 | 2688 | 0.010 |
Why?
|
| Tuberculin Test | 1 | 1996 | 205 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2009 | 3441 | 0.010 |
Why?
|
| Prevalence | 1 | 2012 | 15721 | 0.010 |
Why?
|
| Isoniazid | 1 | 1996 | 283 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2012 | 12952 | 0.010 |
Why?
|
| Homicide | 1 | 1997 | 294 | 0.010 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1995 | 242 | 0.010 |
Why?
|
| Candidiasis | 1 | 1995 | 365 | 0.010 |
Why?
|
| Hospitalization | 1 | 2011 | 10707 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 64681 | 0.010 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1995 | 529 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2003 | 3253 | 0.010 |
Why?
|
| Odds Ratio | 1 | 1998 | 9652 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 1998 | 12052 | 0.000 |
Why?
|
| Survivors | 1 | 1995 | 2369 | 0.000 |
Why?
|
| Heart Diseases | 1 | 1997 | 2795 | 0.000 |
Why?
|
| Logistic Models | 1 | 1998 | 13249 | 0.000 |
Why?
|
| Tuberculosis | 1 | 1995 | 2016 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1998 | 15308 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 1998 | 22174 | 0.000 |
Why?
|
| Incidence | 1 | 1996 | 21365 | 0.000 |
Why?
|
| HIV Infections | 1 | 2001 | 17347 | 0.000 |
Why?
|